PATENT CLAIM ANALYSIS

Application Number: 15946955
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "395000"]

Abstract:
The disclosed subject matter provides methods using and kits comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Claim (Index 1):
A method of treating a tumor, comprising administering to a human subject in need thereof a solid, oral dosage form comprising a compound of formula (I) or pharmaceutically acceptable salt thereof,\n wherein the solid, oral dosage form provides an AUC 0-t  (0-24 hours) of about 800-15,000 hr\u00b7ng/mL after a single administration, \n wherein the solid, oral dosage form is administered at a dosage of about 100-1,200 mg/day 1-7 days per week, up to about 2,800 mg/week.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.04348
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15255910', '15178390', '15683408', '12763991', '15137323']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6762724602519339
- 35 USC 102 Novelty (BERT): 0.5946677440095021
- Combined Prediction Score: 0.6681119886276907
- Mean Citation Score: 303.269732
- Max Citation Score: 502.8837
- Similarity Product: 470.2615145417332

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test